These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 36971354)

  • 1. Antigenic mapping and functional characterization of human New World hantavirus neutralizing antibodies.
    Engdahl TB; Binshtein E; Brocato RL; Kuzmina NA; Principe LM; Kwilas SA; Kim RK; Chapman NS; Porter MS; Guardado-Calvo P; Rey FA; Handal LS; Diaz SM; Zagol-Ikapitte IA; Tran MH; McDonald WH; Meiler J; Reidy JX; Trivette A; Bukreyev A; Hooper JW; Crowe JE
    Elife; 2023 Mar; 12():. PubMed ID: 36971354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizing Monoclonal Antibodies against the Gn and the Gc of the Andes Virus Glycoprotein Spike Complex Protect from Virus Challenge in a Preclinical Hamster Model.
    Duehr J; McMahon M; Williamson B; Amanat F; Durbin A; Hawman DW; Noack D; Uhl S; Tan GS; Feldmann H; Krammer F
    mBio; 2020 Mar; 11(2):. PubMed ID: 32209676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential lymphocyte and antibody responses in deer mice infected with Sin Nombre hantavirus or Andes hantavirus.
    Schountz T; Quackenbush S; Rovnak J; Haddock E; Black WC; Feldmann H; Prescott J
    J Virol; 2014 Aug; 88(15):8319-31. PubMed ID: 24829335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection.
    Engdahl TB; Kuzmina NA; Ronk AJ; Mire CE; Hyde MA; Kose N; Josleyn MD; Sutton RE; Mehta A; Wolters RM; Lloyd NM; Valdivieso FR; Ksiazek TG; Hooper JW; Bukreyev A; Crowe JE
    Cell Rep; 2021 May; 35(5):109086. PubMed ID: 33951434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantaviruses.
    Mittler E; Wec AZ; Tynell J; Guardado-Calvo P; Wigren-Byström J; Polanco LC; O'Brien CM; Slough MM; Abelson DM; Serris A; Sakharkar M; Pehau-Arnaudet G; Bakken RR; Geoghegan JC; Jangra RK; Keller M; Zeitlin L; Vapalahti O; Ulrich RG; Bornholdt ZA; Ahlm C; Rey FA; Dye JM; Bradfute SB; Strandin T; Herbert AS; Forsell MNE; Walker LM; Chandran K
    Sci Transl Med; 2022 Mar; 14(636):eabl5399. PubMed ID: 35294259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular insight into the neutralization mechanism of human-origin monoclonal antibody AH100 against Hantaan virus.
    Wang F; Liu T; Liao L; Chai Y; Qi J; Gao F; Liang M; Gao GF; Wu Y
    J Virol; 2024 Aug; 98(8):e0088324. PubMed ID: 39078157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral Immunity to Hantavirus Infection.
    Engdahl TB; Crowe JE
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32669473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A hantavirus pulmonary syndrome (HPS) DNA vaccine delivered using a spring-powered jet injector elicits a potent neutralizing antibody response in rabbits and nonhuman primates.
    Kwilas S; Kishimori JM; Josleyn M; Jerke K; Ballantyne J; Royals M; Hooper JW
    Curr Gene Ther; 2014; 14(3):200-10. PubMed ID: 24867065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vesicular Stomatitis Virus-Based Vaccines Provide Cross-Protection against Andes and Sin Nombre Viruses.
    Warner BM; Stein DR; Jangra RK; Slough MM; Sroga P; Sloan A; Frost KL; Booth S; Chandran K; Safronetz D
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31337019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS).
    Hooper JW; Josleyn M; Ballantyne J; Brocato R
    Vaccine; 2013 Sep; 31(40):4314-21. PubMed ID: 23892100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Basis for a Neutralizing Antibody Response Elicited by a Recombinant Hantaan Virus Gn Immunogen.
    Rissanen I; Krumm SA; Stass R; Whitaker A; Voss JE; Bruce EA; Rothenberger S; Kunz S; Burton DR; Huiskonen JT; Botten JW; Bowden TA; Doores KJ
    mBio; 2021 Aug; 12(4):e0253120. PubMed ID: 34225492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tracing Transmission of Sin Nombre Virus and Discovery of Infection in Multiple Rodent Species.
    Goodfellow SM; Nofchissey RA; Schwalm KC; Cook JA; Dunnum JL; Guo Y; Ye C; Mertz GJ; Chandran K; Harkins M; Domman DB; Dinwiddie DL; Bradfute SB
    J Virol; 2021 Nov; 95(23):e0153421. PubMed ID: 34549977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical evaluation of a fully human, quadrivalent-hantavirus polyclonal antibody derived from a non-human source.
    Brocato RL; Wu H; Kwilas SA; Principe LM; Josleyn M; Shamblin J; Chivukula P; Bausch C; Luke T; Sullivan EJ; Hooper JW
    mBio; 2024 Oct; 15(10):e0160024. PubMed ID: 39258903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Truncated hantavirus nucleocapsid proteins for serotyping Sin Nombre, Andes, and Laguna Negra hantavirus infections in humans and rodents.
    Koma T; Yoshimatsu K; Pini N; Safronetz D; Taruishi M; Levis S; Endo R; Shimizu K; Yasuda SP; Ebihara H; Feldmann H; Enria D; Arikawa J
    J Clin Microbiol; 2010 May; 48(5):1635-42. PubMed ID: 20335425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hantaan/Andes virus DNA vaccine elicits a broadly cross-reactive neutralizing antibody response in nonhuman primates.
    Hooper JW; Custer DM; Smith J; Wahl-Jensen V
    Virology; 2006 Mar; 347(1):208-16. PubMed ID: 16378630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two recombinant human monoclonal antibodies that protect against lethal Andes hantavirus infection in vivo.
    Garrido JL; Prescott J; Calvo M; Bravo F; Alvarez R; Salas A; Riquelme R; Rioseco ML; Williamson BN; Haddock E; Feldmann H; Barria MI
    Sci Transl Med; 2018 Nov; 10(468):. PubMed ID: 30463919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hantaviruses: an emerging public health threat in India? A review.
    Chandy S; Abraham S; Sridharan G
    J Biosci; 2008 Nov; 33(4):495-504. PubMed ID: 19208975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of VSV Pseudovirus and Focus Reduction Neutralization Assays for Measurement of Anti-
    Vial C; Whitaker A; Wilhelm J; Ovalle J; Perez R; Valdivieso F; Ferres M; Martinez-Valdebenito C; Eisenhauer P; Mertz GJ; Hooper JW; Botten JW; Vial PA
    Front Cell Infect Microbiol; 2020; 10():444. PubMed ID: 33042854
    [No Abstract]   [Full Text] [Related]  

  • 19. New ecological aspects of hantavirus infection: a change of a paradigm and a challenge of prevention--a review.
    Zeier M; Handermann M; Bahr U; Rensch B; Müller S; Kehm R; Muranyi W; Darai G
    Virus Genes; 2005 Mar; 30(2):157-80. PubMed ID: 15744574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two Point Mutations in Old World Hantavirus Glycoproteins Afford the Generation of Highly Infectious Recombinant Vesicular Stomatitis Virus Vectors.
    Slough MM; Chandran K; Jangra RK
    mBio; 2019 Jan; 10(1):. PubMed ID: 30622188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.